Omada Health, Inc. (OMDA)

Omada Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	4.31	-12.78	-47.14	-67.51	-72.52
Depreciation & Amortization	5.9	5.89	5.5	4.45	4.33
Other Amortization	3.74	3.62	3.03	2.22	1.85
Loss (Gain) From Sale of Assets	0.03	0.01	0	0.15	0.01
Stock-Based Compensation	17.12	12.96	9.42	8.74	6.65
Provision & Write-off of Bad Debts	1.89	1.19	1.76	0.45	0.24
Other Operating Activities	2.39	3.62	-0.19	3.27	-0.4
Change in Accounts Receivable	-25.17	-12.36	-8.81	-5.34	-3.93
Change in Inventory	-0.65	-1.19	0.32	-0.07	-1.95
Change in Accounts Payable	6.8	6.29	0.4	-0.29	-4.99
Change in Unearned Revenue	2.18	5.53	4.65	1.44	1.79
Change in Other Net Operating Assets	5.17	5.47	-3.13	2.76	-0.06
Operating Cash Flow	23.69	18.25	-34.18	-49.74	-68.98
Operating Cash Flow Growth	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Capital Expenditures	-0.96	-1.32	-0.6	-0.42	-0.72
Sale (Purchase) of Intangibles	-5.59	-4.51	-3.27	-2.51	-2
Investing Cash Flow	-6.55	-5.83	-3.86	-2.92	-2.72

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Long-Term Debt Issued	-	-	-	30.96	-
Long-Term Debt Repaid	-	-30.96	-	-30	-
Net Debt Issued (Repaid)	-30.96	-30.96	-	0.96	-
Issuance of Common Stock	16.84	169.9	3.33	1.76	1.74
Other Financing Activities	-3.79	-5.71	-4.54	-2.54	-
Financing Cash Flow	-18.57	133.22	-1.21	0.18	16.32

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Cash Flow	-1.43	145.64	-39.25	-52.48	-55.38

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Free Cash Flow	22.73	16.93	-34.78	-50.15	-69.7
Free Cash Flow Growth	-	-	-	-	-
Free Cash Flow Margin	7.34%	6.51%	-20.48%	-40.85%	-78.15%
Free Cash Flow Per Share	0.37	0.46	-4.50	-7.07	-10.28
Levered Free Cash Flow	11.92	15.34	-14.46	-29.39	-
Unlevered Free Cash Flow	12.13	16.64	-12.03	-26.87	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash Interest Paid	0.63	2.42	3.85	4.09	3.61
Change in Working Capital	-11.68	3.74	-6.57	-1.5	-9.15

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error